• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过酶联免疫吸附试验测定激活血小板中基质金属蛋白酶-1 和 -2 的释放,但不包括 -9。

Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.

机构信息

Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Linköping University, Sweden.

出版信息

Platelets. 2011;22(8):572-8. doi: 10.3109/09537104.2011.583300. Epub 2011 Jul 14.

DOI:10.3109/09537104.2011.583300
PMID:21756063
Abstract

Matrix metalloproteinases (MMPs), in particular MMP-9, have been introduced as novel biomarkers in coronary artery disease. Activated platelets are considered to be a major source of the highly elevated levels of MMPs that are detected in serum compared to plasma. The aim of this study was to clarify if activated platelets release MMPs-1, -2 and -9 as measured by enzyme-linked immunosorbent assays (ELISA). Isolated platelets (separated by several procedures) or platelet-rich plasma (PRP) were stimulated by collagen, thrombin or the TLR2 agonist Pam(3)CSK(4). The concentrations of MMPs-1,-2 and -9 in supernatants were determined by ELISA. In addition, a MMP-9 enzyme activity assay was used as well as immunofluorescent staining of MMPs-1,-2 and 9 in platelets. Isolated platelets stimulated by collagen, thrombin or Pam(3)CSK(4) released significant amounts of MMP-1 to the supernatant measured as either pro- or total-MMP-1. However, there was no detectable release of MMP-2 or -9 from isolated platelets. Collagen-stimulated platelets in PRP released MMP-2, but not -9. Before stimulation; platelets were positive for MMPs-1 and -2, but not -9, as assessed by immunofluorescence. Acting as positive controls, neutrophils were found to release significant amounts of MMP-9. Our findings indicate that activated platelets may be a major source of MMP-1 and to a minor extent MMP-2, in peripheral blood. However, in contrast to what has been argued in previous literature, platelets appear to be only negligible contributors to circulating MMP-9.

摘要

基质金属蛋白酶(MMPs),特别是 MMP-9,已被引入作为冠状动脉疾病的新型生物标志物。与血浆相比,激活的血小板被认为是血清中检测到的高度升高的 MMP 水平的主要来源。本研究的目的是阐明激活的血小板是否通过酶联免疫吸附测定(ELISA)释放 MMP-1、-2 和-9。通过胶原、凝血酶或 TLR2 激动剂 Pam(3)CSK(4)刺激分离的血小板(通过几种程序分离)或富含血小板的血浆(PRP)。通过 ELISA 测定上清液中 MMP-1、-2 和-9 的浓度。此外,还使用 MMP-9 酶活性测定以及血小板中 MMP-1、-2 和 9 的免疫荧光染色。胶原、凝血酶或 Pam(3)CSK(4)刺激的分离血小板向上清液中释放大量 MMP-1,无论是前体 MMP-1 还是总 MMP-1 均可测量。然而,从分离的血小板中未检测到 MMP-2 或-9 的释放。胶原刺激的 PRP 中的血小板释放 MMP-2,但不释放 MMP-9。在刺激之前;通过免疫荧光评估,血小板对 MMP-1 和 -2 呈阳性,但对 -9 呈阴性。作为阳性对照,发现中性粒细胞大量释放 MMP-9。我们的研究结果表明,在周围血液中,激活的血小板可能是 MMP-1 的主要来源,并且在较小程度上是 MMP-2 的来源。然而,与之前文献中的论点相反,血小板似乎对循环 MMP-9 的贡献微不足道。

相似文献

1
Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.通过酶联免疫吸附试验测定激活血小板中基质金属蛋白酶-1 和 -2 的释放,但不包括 -9。
Platelets. 2011;22(8):572-8. doi: 10.3109/09537104.2011.583300. Epub 2011 Jul 14.
2
On the origin of matrix metalloproteinase-2 and -9 in blood platelets.血小板中基质金属蛋白酶-2 和 -9 的起源。
Platelets. 2012;23(6):467-74. doi: 10.3109/09537104.2012.682103. Epub 2012 May 30.
3
Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.血小板可溶性 CD40L 和基质金属蛋白酶 9 活性是白塞病患者的促炎介质。
Thromb Haemost. 2012 Jan;107(1):88-98. doi: 10.1160/TH11-08-0556. Epub 2011 Nov 24.
4
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.血小板在急性冠脉综合征患者的冠状动脉循环中释放基质金属蛋白酶-2:在持续血小板激活中的可能作用。
Eur Heart J. 2011 Feb;32(3):316-25. doi: 10.1093/eurheartj/ehq390. Epub 2010 Oct 28.
5
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.基质金属蛋白酶-9和-2对血小板聚集的差异调节
Thromb Haemost. 1999 Dec;82(6):1730-5.
6
Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation.中性粒细胞P-选择素糖蛋白配体-1与血小板P-选择素的结合增强金属蛋白酶2的分泌及血小板-中性粒细胞聚集。
Thromb Haemost. 2005 Dec;94(6):1230-5. doi: 10.1160/TH05-05-0344.
7
Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.基质金属蛋白酶9通过可溶性CD40配体的释放参与克罗恩病相关的血小板过度活化。
Gut. 2009 Jul;58(7):920-8. doi: 10.1136/gut.2008.150318. Epub 2008 Nov 27.
8
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.血小板在人体血管损伤部位可在体内释放活性基质金属蛋白酶-2:阿司匹林无法抑制其释放。
Br J Haematol. 2007 Jul;138(2):221-30. doi: 10.1111/j.1365-2141.2007.06632.x.
9
Activation of cartilage matrix metalloproteinases by activated protein C.活化蛋白C对软骨基质金属蛋白酶的激活作用。
Arthritis Rheum. 2009 Mar;60(3):780-91. doi: 10.1002/art.24303.
10
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.基质金属蛋白酶、其组织抑制剂与结直肠癌分期
Br J Surg. 2000 Sep;87(9):1215-21. doi: 10.1046/j.1365-2168.2000.01531.x.

引用本文的文献

1
The Effect of Leukocyte Removal and Matrix Metalloproteinase Inhibition on Platelet Storage Lesions.白细胞去除和基质金属蛋白酶抑制对血小板储存损伤的影响。
Cells. 2024 Mar 13;13(6):506. doi: 10.3390/cells13060506.
2
Platelet Membrane Receptor Proteolysis: Implications for Platelet Function.血小板膜受体蛋白水解:对血小板功能的影响。
Front Cardiovasc Med. 2021 Jan 8;7:608391. doi: 10.3389/fcvm.2020.608391. eCollection 2020.
3
Effects of functionalized silver nanoparticles on aggregation of human blood platelets.功能化银纳米粒子对人血血小板聚集的影响。
Int J Nanomedicine. 2019 Sep 11;14:7399-7417. doi: 10.2147/IJN.S213499. eCollection 2019.
4
Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia.基质金属蛋白酶 2 和 9、 toll 样受体 4 及血小板-白细胞聚集体形成在脓毒症相关血小板减少症中的作用。
PLoS One. 2018 May 7;13(5):e0196478. doi: 10.1371/journal.pone.0196478. eCollection 2018.
5
Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.基质金属蛋白酶-9 作为结直肠癌生物标志物的稳定性。
Med Oncol. 2018 Mar 9;35(4):50. doi: 10.1007/s12032-018-1109-4.
6
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.MMP - 2、MMP - 9、TIMP - 4与稳定型冠状动脉疾病的糖尿病和非糖尿病患者对阿司匹林的反应:一项初步研究
Biomed Res Int. 2017;2017:9352015. doi: 10.1155/2017/9352015. Epub 2017 Jul 10.
7
Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.基质金属蛋白酶在血浆和血清中的水平存在差异——癌症生物标志物分析的相关方面。
Br J Cancer. 2016 Sep 6;115(6):703-6. doi: 10.1038/bjc.2016.127. Epub 2016 May 17.
8
Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets.血链球菌诱导血小板释放细胞因子和基质金属蛋白酶-1
BMC Immunol. 2014 Apr 22;15:15. doi: 10.1186/1471-2172-15-15.
9
Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients.糖尿病患者和血糖正常患者的CD34⁺祖细胞源性泡沫细胞中MMP-9活性的差异
Herz. 2015 May;40 Suppl 3:269-76. doi: 10.1007/s00059-013-4012-y. Epub 2013 Dec 5.
10
MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix.基质金属蛋白酶抑制作为增强骨骼肌和肌腱细胞外基质愈合的一种潜在方法。
J Appl Physiol (1985). 2013 Sep;115(6):884-91. doi: 10.1152/japplphysiol.00137.2013. Epub 2013 May 2.